表紙:心臓再同期療法の市場規模、シェア、動向分析レポート:製品別(CRT-除細動器、CRT-ペースメーカー)、エンドユーザー別(病院、心臓センター、その他)、地域別、セグメント別予測、2023年~2030年
市場調査レポート
商品コード
1171050

心臓再同期療法の市場規模、シェア、動向分析レポート:製品別(CRT-除細動器、CRT-ペースメーカー)、エンドユーザー別(病院、心臓センター、その他)、地域別、セグメント別予測、2023年~2030年

Cardiac Resynchronization Therapy Market Size, Share & Trends Analysis Report By Product (CRT-Defibrillator, CRT-Pacemaker), By End-use (Hospitals, Cardiac Centers, Others), By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 150 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
心臓再同期療法の市場規模、シェア、動向分析レポート:製品別(CRT-除細動器、CRT-ペースメーカー)、エンドユーザー別(病院、心臓センター、その他)、地域別、セグメント別予測、2023年~2030年
出版日: 2022年11月23日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

心臓再同期療法市場の成長と動向

Grand View Research社の最新レポートによると、心臓再同期療法の世界市場規模は2030年までに62億3000万米ドルに達すると予測されています。この市場は、2023年から2030年にかけて4.8%の有利なCAGRで拡大すると予測されています。市場成長の主な要因は、主要企業による取り組みの拡大、製品の進歩の高まり、エンドユーザーによる製品採用の増加などです。

CRT市場は、COVID-19の大流行によって大きな影響を受けました。COVID-19が市場に与えた主な影響としては、需要の鈍化、売上高の減少、運用上のハードルや選択的処置のキャンセルによるサプライチェーンの混乱などがあります。例えば、心調律管理機器事業の大手であるアボットは、2020年の心血管事業の収益成長率の低下を報告しています。ボストン・サイエンティフィックは、2020年に全地域で売上高が減少すると報告しています。2021年第3四半期には、心調律管理事業が総売上高15億米ドルを占め、同社の売上は徐々に回復しています。

さらに、COVID-19は、2020年4月24日に終了したMedtronicの第4四半期の業績にマイナスの影響を与えました。メドトロニックの機器を使用した選択的治療および準選択的治療の延期は、企業に影響を与えました。COVID-19以外の緊急処置に人々が消極的なのは、同社の新興製品群に影響を与えます。2021年までに、同社の売上高はプラス領域に戻っています。同社の心臓&リズム管理ポートフォリオの売上は、2021年10月までの半年間で前年比11%増となっています。

市場の主要企業による製品の進歩やイニシアチブの増加は、今後数年間の市場成長を促進すると予想されます。例えば、2020年2月、メドトロニックは、AdaptivCRTおよびEffectivCRTアルゴリズムなどのスマート機能を組み合わせた心臓再同期療法除細動器(CRT-Ds)についてCEマーク認可を取得しました。同様に、2020年7月、アボット社は、Bluetooth機能を搭載した心臓再同期療法除細動器(CRT-D)機器について、米国FDAから認可を取得しました。

心臓再同期療法市場レポートハイライト

心臓再同期療法市場は2022年に42億6000万米ドルとなり、予測期間中にCAGR4.8%で成長すると予想される

急速な技術進歩は、市場成長をエスカレートさせる主要な動向の1つです。また、座りっぱなしのライフスタイルの採用や、心血管疾患の有病率の上昇に伴う老年人口の増加も、市場の成長を促進しています。

2022年の製品別市場シェアは、CRT-Dが圧倒的でした。これは、これらのデバイスの高い採用率、幅広いアプリケーション、心血管疾患の有病率の上昇に起因します。

2022年の市場では、CRT-Pが顕著なシェアを占め、予測期間中に最も速い速度で成長すると予測されています。これは、世界中で適応症が拡大していることと、心不全の有病率が高いことに起因しています。

2022年には、病院セグメントが52.08%超の最大市場シェアを占めました。これらのセンターは、診断後にCRTデバイスを設置する主要なポイントであることに起因しています。

北米は、確立されたヘルスケアシステムと一人当たりの医療費により、2022年に49.9%を超える最大の市場シェアを占め、予測期間中の市場成長を促進することが期待されています。

目次

第1章 調査手法と範囲

  • 市場セグメンテーションと範囲
  • 調査手法
  • 情報調達
    • 購入したデータベース:
    • Gvrの内部データベース
    • 二次情報
    • 1次調査:
    • 1次調査の詳細
  • 情報またはデータ分析
    • データ分析モデル
  • 市場の策定と検証
  • モデルの詳細
    • コモディティフロー分析
  • 二次情報のリスト
  • 報告の目的

第2章 エグゼクティブサマリー

  • 心臓再同期療法(CRT)市場の見通し、2018~2030年(USD Million)
  • 心臓再同期療法(CRT)市場の概要、2022年

第3章 心臓再同期療法(CRT)市場の変数、動向、範囲

  • 市場系列の見通し
    • 親市場の見通し
    • アンシラリー市場の見通し
  • 浸透と成長の見通しのマッピング
  • 心臓再同期療法(CRT)市場力学
    • 市場促進要因分析
      • 心血管疾患の有病率の増加
      • 技術の進歩
      • 座りがちなライフスタイルの台頭
      • 高齢者人口の増加
    • 市場抑制要因分析
      • 製品回収
      • デバイスの高コスト
  • 規制の枠組み
    • 北米
    • 欧州
    • アジア太平洋
    • 中南米
    • 中東・アフリカ
  • 心臓再同期療法(CRT)市場分析ツール
    • 業界分析- ポーターズ
      • 供給企業の交渉力:低い
      • 買い手の交渉力:低い
      • 代替品の脅威:高
      • 新規参入業者の脅威:低
      • 競争企業間の敵対関係:中程度
    • 心臓再同期療法(CRT)-SWOT分析、要因別(政治と法律、経済、技術)
      • 政治と法律の情勢
      • 経済情勢
      • 社会情勢
      • テクノロジー情勢
  • 米国の心臓再同期療法施術コードリスト
    • 初期、アップグレード、交換用 CRTシステムインプラントのCPTコードリスト
    • 初期、アップグレード、および交換用 CRTシステムインプラント用のICD-10-PCSコード
  • 世界の心臓再同期療法(CRT)市場、Asp、地域別2018年-2030年(USD)
    • 世界のCRT除細動器、Asp、地域別2018~2030年(USD)
    • 世界のCRTペースメーカー、Asp、地域別2018~2030年(USD)
  • 世界の心臓再同期療法(CRT)市場、単位量、地域別2018年-2030年(USD)
    • 世界のCRT除細動器、台数、地域別2018~2030年(米ドル)
    • 世界のCRTペースメーカー、台数、地域別2018年-2030年(USD)
  • COVID-19影響分析
    • COVID-19の影響と将来のシナリオ
    • 市場関係者への影響
      • 競合別要因と戦略

第4章 心臓再同期療法(CRT)市場:製品の推定・動向分析

  • 製品市場シェア分析、2022年および2030年
  • 製品ダッシュボード
  • CRT-D
  • CRT-P

第5章 心臓再同期療法(CRT)市場:最終用途の推定・動向分析

  • 最終用途の市場シェア分析、2022年および2030年
  • エンドユースダッシュボード
  • 病院
  • 心臓センター
  • その他

第6章 心臓再同期療法(CRT)市場:地域別の推定・動向分析、製品別、最終用途

  • 地域市場のスナップショット
  • 地域市場シェア分析、2022年および2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • 韓国
  • ラテンアメリカ
    • メキシコ
    • ブラジル
    • アルゼンチン
  • 中東およびアフリカ(MEA)
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第7章 競合情勢

  • 企業プロファイル
    • ABBOTT
      • 会社概要
      • 製品のベンチマーク
      • 財務実績
      • 戦略的イニシアチブ
    • BOSTON SCIENTIFIC CORPORATION
      • 会社概要
      • 製品のベンチマーク
      • 財務実績
      • 戦略的イニシアチブ
    • MEDTRONIC
      • 会社概要
      • 製品のベンチマーク
      • 財務実績
      • 戦略的イニシアチブ
    • BIOTRONIK SE &CO. KG
      • 会社概要
      • 製品のベンチマーク
      • 財務実績
      • 戦略的イニシアチブ
    • MICROPORT SCIENTIFIC CORPORATION
      • 会社概要
      • 製品のベンチマーク
      • 財務実績
      • 戦略的イニシアチブ
    • Livanova plc.
      • 会社概要
      • 製品のベンチマーク
      • 財務実績
      • 戦略的イニシアチブ
  • 市場参加の分類
    • 会社の市況分析
  • Major Deals &Strategic Alliances Analysis
図表

List of Tables

  • TABLE 1 List of secondary sources
  • TABLE 2 List of key companies
  • TABLE 3 U.S. Cardiac Resynchronization Therapy Procedure Code List
  • TABLE 4 CPT Codes list for Initial, Upgrade, and Replacement CRT system implant
  • TABLE 5 ICD-10-PCS Codes for Initial, Upgrade, and Replacement CRT system implant
  • TABLE 6 Global cardiac resynchronization therapy (CRT) Market, ASP, by Region 2018 - 2030 (USD)
  • TABLE 7 Global CRT-Defibrillator, ASP, by Region 2018 - 2030 (USD)
  • TABLE 8 Global CRT-Pacemaker, ASP, by Region 2018 - 2030 (USD)
  • TABLE 9 Global cardiac resynchronization therapy (CRT) Market, Unit Volume, by Region 2018 - 2030 (USD)
  • TABLE 10 Global CRT-Defibrillator, Unit Volume, by Region 2018 - 2030 (USD)
  • TABLE 11 Global CRT-Pacemaker, Unit Volume, by Region 2018 - 2030 (USD)
  • TABLE 12 Impact on Market Players
  • TABLE 13 Global Cardiac Resynchronization Therapy market, by region, 2018 - 2030 (USD Million)
  • TABLE 14 Global Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 15 Global Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 16 North America Cardiac Resynchronization Therapy market, by country, 2018 - 2030 (USD Million)
  • TABLE 17 North America Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 18 North America Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 19 U.S. Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 20 U.S. Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 21 Canada Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 22 Canada Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 23 Europe Cardiac Resynchronization Therapy market, by country, 2018 - 2030 (USD Million)
  • TABLE 24 Europe Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 25 Europe Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 26 UK Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 27 UK Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 28 Germany Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 29 Germany Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 30 France Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 31 France Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 32 Italy Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 33 Italy Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 34 Spain Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 35 Spain Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 36 Asia Pacific Cardiac Resynchronization Therapy market, by country, 2018 - 2030 (USD Million)
  • TABLE 37 Asia Pacific Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 38 Asia Pacific Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 39 China Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 40 China Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 41 Japan Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 42 Japan Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 43 India Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 44 India Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 45 Australia Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 46 Australia Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 47 South Korea Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 48 South Korea Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 49 Latin America Cardiac Resynchronization Therapy market, by country, 2018 - 2030 (USD Million)
  • TABLE 50 Latin America Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 51 Latin America Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD
  • TABLE 52 Brazil Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 53 Brazil Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 54 Mexico Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 55 Mexico Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 56 Argentina Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 57 Argentina Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 58 MEA Cardiac Resynchronization Therapy market, by country, 2018 - 2030 (USD Million)
  • TABLE 59 MEA Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 60 MEA Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 61 South Africa Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 62 South Africa Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 63 South Africa Cardiac Resynchronization Therapy market, by application, 2018 - 2030 (USD Million)
  • TABLE 64 Saudi Arabia Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 65 Saudi Arabia Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)
  • TABLE 66 UAE Cardiac Resynchronization Therapy market, by product, 2018 - 2030 (USD Million)
  • TABLE 67 UAE Cardiac Resynchronization Therapy market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • FIG. 1 Market segmentation
  • FIG. 2 Market research process
  • FIG. 3 Data triangulation techniques
  • FIG. 4 Primary research pattern
  • FIG. 5 Market research approaches
  • FIG. 6 Value-chain-based sizing & forecasting
  • FIG. 7 QFD modeling for market share assessment
  • FIG. 8 Market formulation & validation
  • FIG. 9 Commodity flow analysis
  • FIG. 10 Cardiac Resynchronization Therapy (CRT) market revenue, 2018 - 2030 (USD Million)
  • FIG. 11 Cardiac Resynchronization Therapy (CRT) market snapshot, 2022 (USD Million)
  • FIG. 12 Parent Market Analysis
  • FIG. 13 Ancillary Market Analysis
  • FIG. 14 Penetration & growth prospect mapping by end-use, 2022
  • FIG. 15 Cardiac Resynchronization Therapy (CRT) market dynamics
  • FIG. 16 Cardiac Resynchronization Therapy (CRT) market driver impact
  • FIG. 17 Population aged 65 Years and Above (% of Total Population), 2020
  • FIG. 18 Cardiac Resynchronization Therapy (CRT) market restraint impact
  • FIG. 19 COVID-19 Impact Analysis
  • FIG. 20 Cardiac Resynchronization Therapy (CRT) market: Product movement analysis
  • FIG. 21 Cardiac Resynchronization Therapy (CRT) market: Product dashboard
  • FIG. 22 Global CRT-D market, 2018 - 2030 (USD Million)
  • FIG. 23 Global CRT-P market, 2018 - 2030 (USD Million)
  • FIG. 24 Cardiac Resynchronization Therapy (CRT) market: End-use movement analysis
  • FIG. 25 Cardiac Resynchronization Therapy (CRT) End-use dashboard
  • FIG. 26 Prevalence of Heart, Stroke, and Vascular Disease Among Men Aged 18 & Above, By Age Group, 2018 - 2018
  • FIG. 27 Prevalence of Heart, Stroke, and Vascular Disease Among Women Aged 18 & Above, By Age Group, 2018 - 2018
  • FIG. 28 Global hospital market, 2018 - 2030 (USD Million)
  • FIG. 29 Global cardiac centers market, 2018 - 2030 (USD Million)
  • FIG. 30 Global other end-users market, 2018 - 2030 (USD Million)
  • FIG. 31 Regional marketplace: Key takeaways
  • FIG. 32 Regional outlook, 2022 & 2030
  • FIG. 33 North America Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 34 Leading causes of deaths in the U.S.
  • FIG. 35 U.S. Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 36 Canada Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 37 Europe Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 38 UK Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 39 Germany Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 40 France Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 41 Italy Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 42 CRT Devices Implanted in Spain in 2020
  • FIG. 43 Spain Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 44 Asia Pacific Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 45 Japan Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 46 China Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 47 India Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 48 Australia Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 49 South Korea Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 50 Latin America Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 51 Mexico Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 52 Brazil Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 53 Argentina Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 54 MEA Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 55 South Africa Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 56 Saudi Arabia Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 57 UAE Cardiac Resynchronization Therapy (CRT) market, 2018 - 2030 (USD Million)
  • FIG. 58 Market Participant Categorization
  • FIG. 59 Company market position analysis
  • FIG. 60 Major deals & strategic alliances analysis
目次
Product Code: GVR-1-68038-347-8

Cardiac Resynchronization Therapy Market Growth & Trends:

The global cardiac resynchronization therapy market size is anticipated to reach USD 6.23 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a lucrative CAGR of 4.8% from 2023 to 2030. The key factors driving the market growth include growing initiatives by key companies, rising product advancements, and increasing product adoption by end users

The CRT market was significantly impacted by the COVID-19 pandemic. Some of the major impacts of COVID-19 on the market include demand slowdown, fall in sales, and supply chain disruption due to the cancellation of operational hurdles and elective procedures. For instance, Abbott, one of the major players in the cardiac rhythm management device business, reported a decline in revenue growth of the cardiovascular business in 2020. Boston Scientific has reported a decline in sales across all regions in 2020. By Q3 2021, the company's sales recovered gradually with the cardiac rhythm management segment accounting for USD 1.5 billion in total revenue.

Furthermore, COVID-19 had a negative impact on Medtronic's fourth-quarter financial performance, which ended on April 24, 2020. Postponed elective and semi-elective treatments using Medtronic devices had an impact on the corporation. People's reluctance to undertake non-COVID-19 emergency procedures has an impact on the company's emerging product lines. By 2021, the company's sales had returned to positive territory. Its cardiac & rhythm management portfolio revenues increased by 11% year on year for the six months ending in October 2021.

Increasing product advancements and initiatives by key market players are expected to propel market growth in the coming years. For instance, in February 2020, Medtronic received the CE mark clearance for its cardiac resynchronization therapy defibrillators (CRT-Ds) combined with smart features such as AdaptivCRT and EffectivCRT algorithms. Similarly, in July 2020, Abbott received approval from the US FDA for its cardiac resynchronization therapy defibrillator (CRT-D) devices equipped with Bluetooth features.

Cardiac Resynchronization Therapy Market Report Highlights:

  • The Cardiac Resynchronization Therapy market was valued at USD 4.26 billion in 2022 and is expected to grow at a CAGR of 4.8% during the forecast period
  • Rapid technological advancements are one of the key trends escalating market growth. The adoption of a sedentary lifestyle, the growing geriatric population along with the increasing prevalence of cardiovascular diseases is also stimulating the growth of the market
  • CRT-D segment dominated the market by product in 2022, owing to the high adoption of these devices, wider applications, and growing prevalence of cardiovascular diseases
  • CRT-P held a notable share of the market in 2022 and is projected to grow at the fastest rate over the forecast period. This is owing to growing indications and the high prevalence of heart failure across the globe
  • The hospitals' segment held the largest market share of over 52.08% in 2022, as these centers are the main point of care for CRT device installation after diagnosis
  • North America held the largest market share of over 49.9% in 2022, owing to the well-established healthcare system, and per capita, healthcare spending in this region is expected to fuel the market growth over the forecast period

Table of Contents

Chapter 1 Research Methodology & Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research:
    • 1.3.5 Details Of Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
  • 1.7 List Of Secondary Sources
  • 1.8 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Cardiac Resynchronization Therapy (CRT) Market Outlook, 2018 - 2030 (USD Million)
  • 2.2 Cardiac Resynchronization Therapy (CRT) Market Summary, 2022

Chapter 3 Cardiac Resynchronization Therapy (CRT) Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Ancillary Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Cardiac Resynchronization Therapy (CRT) Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Increasing Prevalence Of Cardiovascular Diseases
      • 3.3.1.2 Technological Advancements
      • 3.3.1.3 Rising Sedentary Lifestyle
      • 3.3.1.4 Increasing Geriatric Population
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Product Recall
      • 3.3.2.2 High Cost Of Device
  • 3.4 Regulatory Framework
    • 3.4.1 North America
    • 3.4.2 Europe
    • 3.4.3 APAC
    • 3.4.4 LATAM
    • 3.4.5 MEA
  • 3.5 Cardiac Resynchronization Therapy (CRT) Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's
      • 3.5.1.1 Bargaining Power Of Suppliers: Low
      • 3.5.1.2 Bargaining Power Of Buyers: Low
      • 3.5.1.3 Threat Of Substitutes: High
      • 3.5.1.4 Threat Of New Entrants: Low
      • 3.5.1.5 Competitive Rivalry: Moderate
    • 3.5.2 Cardiac Resynchronization Therapy (CRT)- Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
      • 3.5.2.1 Political & Legal Landscape
      • 3.5.2.2 Economic Landscape
      • 3.5.2.3 Social Landscape
      • 3.5.2.4 Technology Landscape
  • 3.6 U.S. Cardiac Resynchronization Therapy Procedure Code List
    • 3.6.1 CPT Codes List For Initial, Upgrade, And Replacement CRT System Implant
    • 3.6.2 ICD-10-Pcs Codes For Initial, Upgrade, And Replacement CRT System Implant
  • 3.7 Global Cardiac Resynchronization Therapy (CRT) Market, Asp, By Region 2018 - 2030 (USD)
    • 3.7.1 Global CRT-Defibrillator, Asp, By Region 2018 - 2030 (USD)
    • 3.7.2 Global CRT-Pacemaker, Asp, By Region 2018 - 2030 (USD)
  • 3.8 Global Cardiac Resynchronization Therapy (CRT) Market, Unit Volume, By Region 2018 - 2030 (USD)
    • 3.8.1 Global CRT-Defibrillator, Unit Volume, By Region 2018 - 2030 (USD)
    • 3.8.2 Global CRT-Pacemaker, Unit Volume, By Region 2018 - 2030 (USD)
  • 3.9 Covid-19 Impact Analysis
    • 3.9.1 Covid-19 Impact And Future Scenario
    • 3.9.2 Impact On Market Players
      • 3.9.2.1 Factors And Strategies, By The Competitor

Chapter 4 Cardiac Resynchronization Therapy (CRT) Market: Product Estimates & Trend Analysis

  • 4.1 Product Market Share Analysis, 2022 & 2030
  • 4.2 Product Dashboard
  • 4.3 CRT-D
    • 4.3.1 CRT-D Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 4.4 CRT-P
    • 4.4.1 CRT-P Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 5 Cardiac Resynchronization Therapy (CRT) Market: End-Use Estimates & Trend Analysis

  • 5.1 End-Use Market Share Analysis, 2022 & 2030
  • 5.2 End-Use Dashboard
  • 5.3 Hospital
    • 5.3.1 Hospital Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.4 Cardiac Centers
    • 5.4.1 Cardiac Centers Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5 Others
    • 5.5.1 Other End-Users Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6 Cardiac Resynchronization Therapy (CRT) Market: Regional Estimates & Trend Analysis, By Product, And End-Use

  • 6.1 Regional Market Snapshot
  • 6.2 Region Market Share Analysis, 2022 & 2030
  • 6.3 North America
    • 6.3.1 North America Cardiac Resynchronization Therapy (CRT) Market Estimates And Orecasts, 2018 - 2030 (USD Million)
    • 6.3.2 U.S.
      • 6.3.2.1 U.S. Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3 Canada
      • 6.3.3.1 Canada Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.4 Europe
    • 6.4.1 Europe Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2 UK
      • 6.4.2.1 UK Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.3 Germany
      • 6.4.3.1 Germany Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.4 France
      • 6.4.4.1 France Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.5 Italy
      • 6.4.5.1 Italy Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.4.6 Spain
      • 6.4.6.1 Spain Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.5 Asia Pacific
    • 6.5.1 Asia Pacific Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2 JAPAN
      • 6.5.2.1 Japan Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.3 China
      • 6.5.3.1 China Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.4 India
      • 6.5.4.1 India Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.5 Australia
      • 6.5.5.1 Australia Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.5.6 South Korea
      • 6.5.6.1 South Korea Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.6 Latin America
    • 6.6.1 Latin America Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2 Mexico
      • 6.6.2.1 Mexico Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.3 Brazil
      • 6.6.3.1 Brazil Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.6.4 Argentina
      • 6.6.4.1 Argentina Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
  • 6.7 Middle East & Africa (MEA)
    • 6.7.1 MEA Cardiac Resynchronization Therapy (CRT) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2 South Africa
      • 6.7.2.1 South Africa Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.3 Saudi Arabia
      • 6.7.3.1 Saudi Arabia Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)
    • 6.7.4 UAE
      • 6.7.4.1 UAE Cardiac Resynchronization Therapy (CRT) market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape

  • 7.1 Company Profiles
    • 7.1.1 ABBOTT
      • 7.1.1.1 Company overview
      • 7.1.1.2 Product benchmarking
      • 7.1.1.3 Financial performance
      • 7.1.1.4 Strategic initiatives
    • 7.1.2 BOSTON SCIENTIFIC CORPORATION
      • 7.1.2.1 Company overview
      • 7.1.2.2 Product benchmarking
      • 7.1.2.3 Financial performance
      • 7.1.2.4 Strategic initiatives
    • 7.1.3 MEDTRONIC
      • 7.1.3.1 Company overview
      • 7.1.3.2 Product benchmarking
      • 7.1.3.3 Financial performance
      • 7.1.3.4 Strategic initiatives
    • 7.1.4 BIOTRONIK SE & CO. KG
      • 7.1.4.1 Company overview
      • 7.1.4.2 Product benchmarking
      • 7.1.4.3 Financial performance
      • 7.1.4.4 Strategic initiatives
    • 7.1.5 MICROPORT SCIENTIFIC CORPORATION
      • 7.1.5.1 Company overview
      • 7.1.5.2 Product benchmarking
      • 7.1.5.3 Financial performance
      • 7.1.5.4 Strategic initiatives
    • 7.1.6 Livanova plc.
      • 7.1.6.1 Company overview
      • 7.1.6.2 Product benchmarking
      • 7.1.9.3 Financial performance
      • 7.1.6.4 Strategic initiatives
  • 7.2 Market Participation Categorization
    • 7.7.1 Company Market Position Analysis
  • 7.3 Major Deals & Strategic Alliances Analysis